Table 3:
Examples of management changes after diagnosis for studies of undiagnosed patients unselected for a specific phenotype published in 2014–2018
| Study PMID | First author | Year | Age group | Management changes |
|---|---|---|---|---|
| 30304647 | Splinter K | 2018 | pediatric and adult | 21% (28/132) change in therapy, 37% (49/132) change in care other than therapy, 36% (48/132) variant-specific genetic counseling |
| 28496993 | Bick D | 2017 | pediatric | 75% (6/8) impact on medical management or surveillance, 4 changes in medication, 6 medical surveillance |
| 26633542 | Retterer K | 2016 | pediatric and adult | 5 reported with suggested intervention or treatment |
| 26938784 | Stark Z | 2016 | 0–2 years | 33% (15/46) clinical management changed (3 additional treatment started, 5 treatments stopped or modified) |
| 28567303 | Stavropoulos D | 2016 | <1 month – 18 years | 94% (32/34) change in clinical management |
| 30266093 | Normand E | 2018 | prenatal | 4 medical management changes, 15 reproductive planning, 10 recurrence risk of 19 cases with information |
| 28973083 | Meng L | 2017 | infants (<100 days) | 52 infants affected medical management |